Advancing Precision Medicine in TBI: Biomarkers for Clinical Decision Making

31.2K
views
42
authors
7
articles
Cover image for research topic "Advancing Precision Medicine in TBI: Biomarkers for Clinical Decision Making"
Editors
5
Impact
Loading...
3,962 views
17 citations
Original Research
26 November 2021

Traumatic brain injury (TBI) affects millions of Americans each year and has been shown to disproportionately impact those subject to greater disparities in health. Female sex is one factor that has been associated with disparities in health outcomes, including in TBI, but sex differences in biomarker levels and behavioral outcomes after TBI are underexplored. This study included participants with both blunt and blast TBI with majority rating their TBI as mild. Time since injury was 5.4 (2.0, 15.5) years for females and 6.8 (2.4, 11.3) years for males. The aim of this cross sectional study is to investigate the relationship between postconcussive, depression, and post-traumatic stress disorder (PTSD) symptoms, as well as health related quality of life (HRQOL), and the levels of glial fibrillary acidic protein (GFAP), total tau (t-tau), neurofilament light chain (NfL), and ubiquitin C-terminal hydrolase-L1 (UCH-L1). Behavioral outcomes were evaluated with the Neurobehavioral Symptom Inventory (NSI), Patient Health Questionnaire-9 (PHQ-9), PTSD Checklist- Civilian Version (PCL-C), short form (SF)-36, and plasma levels of total tau, GFAP, NfL, and UCHL-1 measured with the Simoa-HDX. We observed that females had significantly higher levels of GFAP and tau (ps < 0.05), and higher PHQ-9 scores, NSI total scores, NSI- vestibular, NSI-somatosensory, NSI-affective sub-scale scores (ps < 0.05)), than males. In addition, females had lower scores in HRQOL outcomes of role limitations due to emotional problems, vitality, emotional well-being, social functioning, and pain compared to males (ps < 0.05). Correlation analysis showed positive associations between levels of tau and the NSI-total and NSI-cognitive sub-scale scores (ps < 0.05) in females. No significant associations were found for NfL or GFAP with NSI scores. For female participants, negative correlations were observed between tau and NfL concentrations and the SF-36 physical function subscale (ps < 0.05), as well as tau and the social function subscale (p < 0.001), while GFAP levels positively correlated with role limitations due to emotional problems (p = 0.004). No significant associations were observed in males. Our findings suggest that sex differences exist in TBI-related behavioral outcomes, as well as levels of biomarkers associated with brain injury, and that the relationship between biomarker levels and behavioral outcomes is more evident in females than males. Future studies are warranted to corroborate these results, and to determine the implications for prognosis and treatment. The identification of candidate TBI biomarkers may lead to development of individualized treatment guidelines.

6,269 views
26 citations
4,566 views
23 citations
5,691 views
30 citations
Open for submission
Frontiers Logo

Frontiers in Pharmacology

Harnessing Advanced Technologies for Drug Development in Immune Disease Treatment
Edited by Yi Yuan, Zhichao Fan, Jiasi Wu, Juan Dong
Deadline
07 July 2025
Submit a paper
Recommended Research Topics
Frontiers Logo

Frontiers in Pharmacology

Metabolomics, Pharmacometabonomics and Pharmacology
Edited by Houkai Li, Yunping Qiu, Guoxiang Xie
43.1K
views
74
authors
8
articles
Frontiers Logo

Frontiers in Pharmacology

Therapeutic & Diagnosis Target Discovery Based on Metabolomics
Edited by Linsheng Liu, Bei Cao, Hiu Yee Kwan, Jiye Aa, Ying Zhou, Giuseppe Lucarelli
58.6K
views
72
authors
10
articles
Frontiers Logo

Frontiers in Pharmacology

Advance in translational research of preterm birth and related pregnancy
Edited by Nanbert Zhong, Thomas McElrath, Hao Ying
25.2K
views
59
authors
10
articles
Frontiers Logo

Frontiers in Pharmacology

Cancer and inflammatory diseases research: from the basics to the precision medicine
Edited by Adriano Sabino, Elaine Leite, Mariana Quezado, Whocely Victor de Castro, Masamitsu Kanada
30.6K
views
77
authors
11
articles
Frontiers Logo

Frontiers in Pharmacology

Molecular Targets in Oncological and Hematological Disease Management: Innovations in Precision Medicine
Edited by Adrian Bogdan Tigu, Stefan Eugen Szedlacsek, Gregory Wiedman
40.9K
views
93
authors
10
articles